Key result
Diffusely increased myocardial extracellular volume was present in 8% of patients and was independently associated with increased left ventricular size (P=0.001).
Why the study?
Myocardial extracellular volume fraction (ECV) using CMR can identify diffuse lesions not detected by LGE, but its prevalence and relationship to other CMR findings required investigation.
Does myocardial extracellular volume fraction (ECV) mapping provide additional diagnostic information beyond late gadolinium enhancement (LGE) in patients with known or suspected heart disease?
Observational (n=609)
Does myocardial extracellular volume fraction (ECV) mapping provide additional diagnostic information beyond late gadolinium enhancement (LGE) in patients with known or suspected heart disease?
p-value: p=0.001
ECV mapping by CMR identifies diffuse myocardial changes independent of focal LGE, providing additional diagnostic value related to LV remodeling.
Diffusely increased ECV may mark LV remodeling beyond focal LGE; leaves open its incremental diagnostic value in routine CMR.
PURPOSE: Myocardial extracellular volume fraction (ECV) using cardiovascular magnetic resonance (CMR) can identify diffuse lesions not detected by late gadolinium enhancement (LGE). We aimed to determine the prevalence of increased ECV and its relation to other CMR findings. MATERIALS AND METHODS: Consecutive patients (n=609, age median [interquartile range] 53 [39 to 66] y, 62% male) underwent CMR at 1.5 T. Focal lesions on LGE images were noted. ECV in regions without focal LGE findings defined diffuse changes. Pronounced increases in left ventricular (LV) end-diastolic volume index and LV mass index, and pronounced decreases in LV ejection fraction were defined as >3 SD from the sex-specific mean in healthy volunteers. RESULTS: Of 609 patients without amyloidosis or hypertrophic cardiomyopathy, 8% had diffusely increased ECV and 5% of all patients had diffusely increased ECV without any focal LGE findings. Multivariate analysis showed that a pronounced increase in the LV end-diastolic volume index was associated with increased ECV (P=0.001), but not LGE (P=0.52). A pronounced decrease in LV ejection fraction was associated with the presence of LGE (P<0.001), but not with increased ECV (P=0.41). CONCLUSIONS: Eight percent of patients in this clinical cohort with known or suspected heart disease had diffusely increased ECV and 60% of these lacked focal LGE findings. LV size is independently associated with increased ECV, whereas systolic dysfunction is independently associated with LGE. This image-based clinical study demonstrates that ECV-CMR provides additional information negligibly related to the results of LGE imaging, and thereby increases the diagnostic yield of CMR.
No takes yet. Share an insight, caveat, or question.
Lundin et al. (2022) conducted an observational in Known or suspected heart disease (n=609). Increased myocardial extracellular volume (ECV) vs. Normal ECV was evaluated on Prevalence of increased ECV and association with left ventricular size and function (p=0.001). Diffusely increased myocardial extracellular volume was present in 8% of patients and was independently associated with increased left ventricular size (P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: